首页> 美国卫生研究院文献>Heliyon >Genotoxicity assessment of saline extract from Pilosocereus gounellei (Cactaceae) and its chemopreventive effect against cyclophosphamide-induced DNA damage
【2h】

Genotoxicity assessment of saline extract from Pilosocereus gounellei (Cactaceae) and its chemopreventive effect against cyclophosphamide-induced DNA damage

机译:仙人掌果盐水提取物的遗传毒性评估及其对环磷酰胺引起的DNA损伤的化学预防作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

(Cactaceae) is used to treat wounds and inflammation. In this study, we evaluated whether the saline extract from its stem would have genotoxic or anti-genotoxic effects. In the genotoxicity evaluation, mice received the extract (500, 1,000, or 2,000 mg/kg) orally while negative and positive controls were treated with saline solution (0.9% NaCl) and cyclophosphamide (CPA, 80 mg/kg i.p.), respectively. In the anti-genotoxicity assay, using other animals, treatments were carried out by administering the extract (500, 1,000 or 2,000 mg/kg) or saline solution (negative control) and then CPA (80 mg/kg i.p.) 1 h later. Genotoxic effects were evaluated by micronucleus test and comet assay using peripheral blood and bone marrow cells. Oral administration of only the extract at 500 and 1,000 mg/kg did not result in genotoxicity. A slight increase in the incidence of micronucleus was observed at the highest dose (2,000 mg/kg). Administration of the extract before CPA reduced the micronucleated polychromatic erythrocytes (MNPCE) number by 49.07–71.43%, and DNA fragmentation in peripheral blood (85.04–94.44%) and bone marrow (87.43–92.70%) cells also decreased. In conclusion, when administered orally at the tested doses, the extract is genotoxically safe, being cautious in doses above 1,000 mg/kg, and has a protective effect against CPA-induced DNA damage.
机译:(仙人掌科)用于治疗伤口和炎症。在这项研究中,我们评估了从其茎中提取的盐提取物是否具有遗传毒性或抗遗传毒性作用。在遗传毒性评估中,小鼠口服提取物(500、1,000或2,000 mg / kg),阴性和阳性对照分别用盐溶液(0.9%NaCl)和环磷酰胺(CPA,80 mg / kg i.p.)处理。在抗遗传毒性试验中,使用其他动物,通过在1小时后服用提取物(500、1,000或2,000 mg / kg)或盐溶液(阴性对照),然后再服用CPA(80 mg / kg腹腔注射)进行治疗。通过使用外周血和骨髓细胞的微核试验和彗星试验评估遗传毒性作用。仅以500和1,000 mg / kg口服提取物不会产生遗传毒性。在最高剂量(2,000 mg / kg)下观察到微核的发生率略有增加。在CPA之前服用提取物可使微核多色红细胞(MNPCE)数量减少49.07–71.43%,外周血和骨髓细胞(87.43–92.70%)的DNA碎片也减少(87.43–92.70%)。总之,当以测试剂量口服给药时,该提取物具有遗传毒性安全性,在1,000 mg / kg以上的剂量时要谨慎,对CPA诱导的DNA损伤具有保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号